2000

International Conference on Harmonisation; Guidance on Q6A Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances.  (29DEC00)
Click here for
txt or pdf
Prepublication display

Electronic Investigational New Drug Application: Cumulative Table of Contents; Public Meeting.   (29DEC00)
Click here for
txt or pdf
Prepublication display

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Guidance for Industry; Changes to an Approved NDA or ANDA.  (21DEC00)
Click here for
txt or pdf
Prepublication display

Draft Guidance for Industry on Cancer Drug and Biological Products--Clinical Data in Marketing Applications; Availability. (09NOV00)
Click here for
txt or pdf
Prepublication display
The Draft Guidance

Applications for FDA Approval to Market a New Drug; Proposed Revision of Postmarketing Reporting Requirements. (07NOV00)
Click here for
txt or pdf
Prepublication display

Revised Guidance for Industry on Submitting and Reviewing Complete Responses to Clinical Holds; Availability. (26OCT00)
Click here for
txt or pdf
Prepublication display
The Guidance

Lilly Research Laboratories et al.; Withdrawal of Approval of 28 New Drug Applications. (13SEP00)
Click here for
txt or pdf
Prepublication document

Agency Information Collection Activities; Proposed Collection; Comment Request; Guidance for Industry: Changes to an Approved NDA or ANDA. (07SEP00)
Click here for
txt or pdf
Prepublication document

Oral Prescription Drugs Offered for Relief of Symptoms of Cough, Cold, or Allergy;Drug Efficacy Study Implementation; Caramiphen Edisylate; Final Actions on Supplemental New Drug Applications. (07JUL00)
Click here for
txt or pdf
Prepublication document

The FDA Review Process for New Product Applications: an Interactive Workshop. (05JUL00)
Click here for
txt or pdf
Prepublication document

Agency Information Collection Activities; Announcement of OMB Approval; Changes to an Approved NDA or ANDA. (05JUN00)
Click here for
txt or pdf

Investigational New Drug Applications; Amendment to Clinical Hold Regulations for Products Intended for Life-Threatening Diseases and Conditions. (01JUN00)
Click here for
txt or pdf
Prepublication document

The Future of the International Conference on Harmonization of Technical Requirements for the Registration of Pharmaceuticals for Human Use (ICH); Notice of Public Meeting. (04MAY00)
Click here for
txt or pdf
Prepublication document

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Guidance for Industry: Changes to an Approved NDA or ANDA. (07APR00)
Click here for
txt or pdf
Prepublication document

John J. Ferrante et al.; Proposal to Withdraw Approval of 158 Abbreviated New Drug Applications; Opportunity for a Hearing. (28MAR00)
Click here for
txt or pdf
Prepublication document

Lilly Research Laboratories et al.; Withdrawal of Approval of 22 New Drug Applications and 36 Abbreviated New Drug Applications.  (20MAR00)
Click here for
txt or pdf
Prepublication document

Draft Guidance for Industry on the Content and Format of New Drug  Applications and Abbreviated New Drug Applications for Certain Positron Emission Tomography Drug Products; Availability (10MAR00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance
Attachment 1
Attachment 2
Attachment 3
Attachment 4

Agency Information Collection Activities; Proposed Collection; Comment Request; General Licensing Provisions: Changes to an Approved Application, Labeling, and Revocation and Suspension.  (07MAR00)
Click here for
txt or pdf
Prepublication document

Guidance for Industry on NDAs: Impurities in Drug Substances (25FEB00)
Click here for
txt or pdf
Prepublication document
The Guidance

Draft Guidance for Industry on IND Meetings for Human Drugs and Biologics; Chemistry, Manufacturing, and Controls Information; Availability. (04FEB00)
Click here for
txt or pdf
Prepublication document
The Draft Guidance

Agency Information Collection Activities; Submission for OMB Review; Comment Request; Application to Market a New Drug, Biologic, or an Antibiotic Drug for Human Use_Form FDA 356h.  (02FEB00)
Click here for
txt or pdf
Prepublication document

Plans to Develop Guidance on Submitting an Archival Copy of an ANDA in Electronic Format; Request for Comments.  (27JAN00)
Click here for
txt or pdf
Prepublication document

New Drug Applications; Drug Master Files. (12JAN00)
Click here for
txt or pdf
Prepublication document